Results 191 to 200 of about 20,321 (243)
Some of the next articles are maybe not open access.
Thermal behaviour of diclofenac, diclofenac sodium and sodium bicarbonate compositions
Journal of Thermal Analysis and Calorimetry, 2007This work aims to investigate the thermal behaviour of diclofenac, diclofenac sodium, and NaHCO3 both as single components and binary mixtures. In particular, the melting point and latent heat of fusion binary diagrams of the diclofenac sodium/diclofenac mixtures at different mole fraction compositions were investigated in order to gain information ...
Irene Pasquali, R. Bettini, F. Giordano
openaire +1 more source
Electrospun Multifunctional Diclofenac Sodium Releasing Nanoscaffold
Journal of Nanoscience and Nanotechnology, 2006Electrospinning is a method utilized to produce nano-scale fibers for tissue engineering applications. A variety of cells are attracted by nano scale surfaces and structures probably due to the similarity of their natural environment scale. In this study, diclofenac sodium (DS) releasing nanofibers were manufactured via electrospinning process.
L, Nikkola +4 more
openaire +2 more sources
Diclofenac Sodium Injection (Dyloject®)
Drugs, 2008*A new formulation of the nonselective NSAID diclofenac sodium suitable for intravenous bolus injection has been developed using hydroxypropyl beta-cyclodextrin as a solubility enhancer (HPbetaCD diclofenac). * HPbetaCD diclofenac intravenous bolus injection was shown to be bioequivalent to the existing parenteral formulation of diclofenac containing ...
Paul L, McCormack, Lesley J, Scott
openaire +2 more sources
Diclofenac Sodium and Bruising
Annals of Internal Medicine, 1990Excerpt To the Editor:No reports to date have described prolonged bleeding time and spontaneous bruising with the use of diclofenac sodium.
Uri Khazan, Mary Toth, Anand Mutgi
openaire +1 more source
Analysis of diclofenac sodium and derivatives
Journal of Pharmaceutical and Biomedical Analysis, 1999There are two reasons explaining why several researchers have carried out the in vitro release studies of diclofenac sodium (DFNa) using pH media of above 6.5. Firstly the pH dependence of solubility, and secondly the intramolecular cyclization suffered under acidic conditions which causes the salt to become inactivated. Nevertheless, many commercially
M E, Palomo, M P, Ballesteros, P, Frutos
openaire +2 more sources
Comparative bioavailability of diclofenac hydroxyethylpyrrolidine vs diclofenac sodium in man
European Journal of Clinical Pharmacology, 1990A phamacokinetic study in man has been made of a new dosage form of diclofenac hydroxyethylpyrrolidine (DIEP); soluble salt packed in sachets was compared with diclofenac sodium as enteric coated tablets. Oral DIEP 2 X 50 mg showed a significant difference in absorption kinetics (ka, lag time and tmax) as compared to oral diclofenac sodium 2 X 50 mg. A
C A, Maggi, P, Lualdi, G, Mautone
openaire +2 more sources
The Journal of Clinical Pharmacology, 2010
Systemic bioavailability and pharmacodynamics of topical diclofenac sodium gel 1% were compared with those of oral diclofenac sodium 50‐mg tablets. In a randomized, 3‐way crossover study, healthy volunteers (n = 40) received three 7‐day diclofenac regimens: (A) 16 g gel applied as 4 g to 1 knee 4 times daily (4 g on surface area 400 cm2), (B) 48 g gel ...
Jean-Luc, Kienzler +2 more
openaire +2 more sources
Systemic bioavailability and pharmacodynamics of topical diclofenac sodium gel 1% were compared with those of oral diclofenac sodium 50‐mg tablets. In a randomized, 3‐way crossover study, healthy volunteers (n = 40) received three 7‐day diclofenac regimens: (A) 16 g gel applied as 4 g to 1 knee 4 times daily (4 g on surface area 400 cm2), (B) 48 g gel ...
Jean-Luc, Kienzler +2 more
openaire +2 more sources
Clinical pharmacy, 1989
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage of diclofenac sodium are reviewed. Diclofenac, the first nonsteroidal anti-inflammatory agent (NSAID) to be approved that is a phenylacetic acid derivative, competes with arachidonic acid for binding to cyclo-oxygenase, resulting in decreased formation of prostaglandins.
openaire +1 more source
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage of diclofenac sodium are reviewed. Diclofenac, the first nonsteroidal anti-inflammatory agent (NSAID) to be approved that is a phenylacetic acid derivative, competes with arachidonic acid for binding to cyclo-oxygenase, resulting in decreased formation of prostaglandins.
openaire +1 more source
Diclofenac Sodium Loaded Multicomponent Implant
AIP Conference Proceedings, 2008Earlier we have reported on developing DS releasing bioabsorbable rods for inhibition of osteolysis [l]. Due to their unsatisfactory drug release profiles we assessed the use of sintering technique of enhancement of drug release in the current study. Melt extruded PLGA 80/20 rods were compounded 8 wt‐% DS.
Lila Nikkola +8 more
openaire +1 more source
Taste masking of diclofenac sodium using microencapsulation
Journal of Microencapsulation, 2002This study addresses how to mask the undesirable taste of diclofenac sodium (DS) without interfering with an adequate rate of drug release. DS microcapsules were successfully prepared using a system of ethylcellulose (EC)-toluene-petroleum ether. The system was optimized by the construction of the phase diagram and determination of the amount of EC ...
M F, Al-Omran +3 more
openaire +2 more sources

